Citation: | Xiu-Sheng Chen, Rui Han, Yan-Ting Liu, Wei Huang, Qi Wang, Xin Xiong, Ying Zhang, Jian-Guo Zhao, Shi-Hua Li, Xiao-Jiang Li, Wei-Li Yang. Comparative analysis of primate and pig cells reveals primate-specific PINK1 expression and phosphorylation. Zoological Research. doi: 10.24272/j.issn.2095-8137.2023.241 |
[1] |
Beilina A, Van Der Brug M, Ahmad R, et al. 2005. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proceedings of the National Academy of Sciences of the United States of America, 102(16): 5703−5708.
|
[2] |
Chen XS, Wang Q, Li SH, et al. 2022. Mitochondrial-dependent and independent functions of PINK1.
|
[3] |
Chen ZY, Zhang Y. 2022. Animal models of Alzheimer's disease: applications, evaluation, and perspectives.
|
[4] |
Chen ZZ, Wang JY, Kang Y, et al. 2021. PINK1 gene mutation by pair truncated sgRNA/Cas9-D10A in cynomolgus monkeys.
|
[5] |
Crook ZR, Housman D. 2011. Huntington's disease: can mice lead the way to treatment?.
|
[6] |
Cummins N, Götz J. 2018. Shedding light on mitophagy in neurons: what is the evidence for PINK1/Parkin mitophagy in vivo?.
|
[7] |
Dawson TM, Golde TE, Lagier-Tourenne C. 2018. Animal models of neurodegenerative diseases.
|
[8] |
Durcan TM, Fon EA. 2015. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications. Genes & Development, 29(10): 989−999.
|
[9] |
Eiyama A, Okamoto K. 2015. PINK1/Parkin-mediated mitophagy in mammalian cells.
|
[10] |
Geisler S, Holmström KM, Skujat D, et al. 2010. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.
|
[11] |
Gispert S, Ricciardi F, Kurz A, et al. 2009. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.
|
[12] |
Goldberg MS, Fleming SM, Palacino JJ, et al. 2003. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons.
|
[13] |
Greene AW, Grenier K, Aguileta MA, et al. 2012. Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment.
|
[14] |
Han R, Liu YT, Li SH, et al. 2023. PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models.
|
[15] |
Kitada T, Tong YR, Gautier CA, et al. 2009. Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice.
|
[16] |
Lazarou M, Sliter DA, Kane LA, et al. 2015. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy.
|
[17] |
Lee JJ, Sanchez-Martinez A, Zarate AM, et al. 2018. Basal mitophagy is widespread in Drosophila but minimally affected by loss of Pink1 or parkin.
|
[18] |
Levine MS, Cepeda C, Hickey MA, et al. 2004. Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect.
|
[19] |
Liu YH, Guardia-Laguarta C, Yin J, et al. 2017. The ubiquitination of PINK1 is restricted to its mature 52-kDa form.
|
[20] |
McGowan E, Eriksen J, Hutton M. 2006. A decade of modeling Alzheimer's disease in transgenic mice.
|
[21] |
McWilliams TG, Prescott AR, Montava-Garriga L, et al. 2018. Basal mitophagy occurs independently of PINK1 in mouse tissues of high metabolic demand.
|
[22] |
Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, et al. 2010. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin.
|
[23] |
Nguyen TN, Padman BS, Lazarou M. 2016. Deciphering the molecular signals of PINK1/parkin mitophagy.
|
[24] |
Otani T, Marchetto MC, Gage FH, et al. 2016. 2D and 3D stem cell models of primate cortical development identify species-specific differences in progenitor behavior contributing to brain size.
|
[25] |
Pickrell AM, Youle RJ. 2015. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease.
|
[26] |
Wan HD, Tang B, Liao X, et al. 2018. Analysis of neuronal phosphoproteome reveals PINK1 regulation of BAD function and cell death. Cell Death & Differentiation, 25(5): 904−917.
|
[27] |
Wang XL, Cao CW, Huang JJ, et al. 2016. One-step generation of triple gene-targeted pigs using CRISPR/Cas9 system.
|
[28] |
Wang ZT, Chan SW, Zhao H, et al. 2023. Outlook of PINK1/Parkin signaling in molecular etiology of Parkinson's disease, with insights into Pink1 knockout models.
|
[29] |
Whitworth AJ, Pallanck LJ. 2017. PINK1/Parkin mitophagy and neurodegeneration-what do we really know in vivo?. Current Opinion in Genetics & Development, 44: 47−53.
|
[30] |
Yan S, Tu ZC, Liu ZM, et al. 2018. A huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington's disease.
|
[31] |
Yan S, Zheng X, Lin YQ, et al. 2023. Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington's disease.
|
[32] |
Yang WL, Guo XY, Tu ZC, et al. 2022. PINK1 kinase dysfunction triggers neurodegeneration in the primate brain without impacting mitochondrial homeostasis. Protein & Cell, 13(1): 26−46.
|
[33] |
Yang WL, Liu YB, Tu ZC, et al. 2019. CRISPR/Cas9-mediated PINK1 deletion leads to neurodegeneration in rhesus monkeys.
|
[34] |
Yin P, Li SH, Li XJ, et al. 2022. New pathogenic insights from large animal models of neurodegenerative diseases. Protein & Cell, 13(10): 707−720.
|
[35] |
Zhou XQ, Xin JG, Fan NN, et al. 2015. Generation of CRISPR/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer.
|
![]() |
![]() |